Evidence map›Paper›PMID 36651607›Full record

ArticleJournal of comparative effectiveness research2023

Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity.

Bart Heeg, Andre Verhoek, Gabriel Tremblay, Ofir Harari, Mohsen Soltanifar, Haitao Chu, Satrajit Roychoudhury, Joseph C Cappelleri

Open access · diamondAbstract readNetwork Meta-Analysis
In one paragraph

Article in Journal of comparative effectiveness research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bart HeegCytel RWAA, Weena 316, 3012 NJ, Rotterdam, The Netherlands.ORCID 0000-0002-9226-3232
Andre VerhoekCytel RWAA, Weena 316, 3012 NJ, Rotterdam, The Netherlands.
Gabriel TremblayCytel RWAA, Canada.
Ofir HarariCytel RWAA, Canada.
Mohsen SoltanifarCytel RWAA, Canada.
Haitao ChuPfizer Inc, 445 Eastern Point Road, MS 8260-2502, Groton, CT 06340, USA.ORCID 0000-0003-0932-598X
Satrajit RoychoudhuryPfizer Inc, 445 Eastern Point Road, MS 8260-2502, Groton, CT 06340, USA.ORCID 0000-0003-4001-3036
Joseph C CappelleriPfizer Inc, 445 Eastern Point Road, MS 8260-2502, Groton, CT 06340, USA.ORCID 0000-0001-9586-0748
Pfizer (United States) · USCytel (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsBayes TheoremDocetaxelHumansNivolumabDocetaxelNivolumabbayesian hierarchical modellingimmunotherapiesindirect treatment comparisonsmixture curenetwork meta-analysisoncologysurvival extrapolation

Identifiers

PMID36651607
PMCPMC10288968
OpenAlexW4317212022

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.